The FDA just approved this ketamine-derived nasal spray for depression treatment
The Food and Drug Administration (FDA) has approved Spravato, a nasal spray developed by Johnson & Johnson, as a standalone treatment for adults with major depressive disorder who have not responded to at least two other antidepressants.
Respondents who said they used other drugs recreationally were also likelier to say they used ketamine during the past year ...
A multidisciplinary approach, including ketamine withdrawal and symptom management, is essential to mitigate long-term ...
US Weekly on MSN5d
What Celebrities and Doctors Have Said About Ketamine Use: Chrissy Teigen, Matthew Perry, MoreCelebrities like Chrissy Teigen and Matthew Perry have been open about using ketamine for their mental health – here's what ...
Inquirer on MSN1d
Controlled drug Ketamine a lifeline for patients with severe depression in S’poreKetamine therapy is now a mainstream prescription for treatment-resistant depression. Read more at straitstimes.com.
IFLScience on MSN12d
Ketamine's Potential To Treat Depression Beautifully Shown In Struggling ZebrafishKetamine’s promising potential to ease depression is one of the reasons why its use has recently skyrocketed in the US and ...
Musk himself has said he uses the drug to treat depression, and he's frequently posted about it on X generally over the years ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback